NRI doc moves court against use of HCQ

Tribune News Service

Updated At : 12:57 PM Apr 17, 2020 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

NRI doc moves court against use of HCQ

New Delhi: A US-based NRI doctor on Thursday moved the Supreme Court against use of Hydroxychloroquine (HCQ) and Azithromycin (AZM) to treat serious Covid-19 cases in India. Petitioner Dr Kunal Saha claimed the use of HCQ and AZM for Covid treatment was based primarily on “anecdotal evidence” and not on “direct scientific data”. The use of these drugs for Covid treatment was “potentially-life threatening”, contended Saha, who is president, People for Better Treatment. tns

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles